International Conference on Pesticide Exposure and Health July 8 12, 2002 NIH, Natcher Conference Ce - PowerPoint PPT Presentation

1 / 28
About This Presentation
Title:

International Conference on Pesticide Exposure and Health July 8 12, 2002 NIH, Natcher Conference Ce

Description:

Dispersants (silica, petroleum distillates) pulmonary fibrosis, lipoid pneumonia, etc. ... Asthma, bronchitis, pneumonia, hay fever, in children (Masley et ... – PowerPoint PPT presentation

Number of Views:85
Avg rating:3.0/5.0
Slides: 29
Provided by: Car53
Category:

less

Transcript and Presenter's Notes

Title: International Conference on Pesticide Exposure and Health July 8 12, 2002 NIH, Natcher Conference Ce


1
International Conference on Pesticide Exposure
and HealthJuly 8 - 12, 2002NIH, Natcher
Conference CenterBethesda, MD USA Respiratory
Disease
  • Arch I. Carson, MD, PhD
  • University of Texas, Houston
  • School of Public Health

2
Effects of pesticides and pesticide preparations
on respiratory function
  • Acute effects
  • Chronic effects
  • Vehicles and dispersants
  • Fumigants

3
Respiratory system
4
Inert ingredients
  • Vehicles (petroleum distillates, diesel fuel,
    ethylene glycol, aromatic hydrocarbons)
    respiratory irritation, pneumonia
  • Dispersants (silica, petroleum distillates)
    pulmonary fibrosis, lipoid pneumonia, etc.

5
Fumigants
  • Sulfotep (Methner and Weldon, 1996)
  • Methyl bromide
  • Aluminum phosphide (phosphine)
  • Etc.

6
Most epidemiological studies have been generic
  • Farming vs. non-farming households in
    Saskatchewan
  • Asthma, bronchitis, pneumonia, hay fever, in
    children (Masley et al., 2000)
  • Greenhouse workers
  • Occupational asthma, respiratory symptoms
    (Illing, 1997)
  • Farmers and grain handlers
  • Cough, wheezing, breathlessness, chest tightness
    (doPico,1996)
  • Indonesian farmers
  • Dry throat, difficulty breathing, chest pain
    (Kishi et al., 1995)

7
Most epidemiological studies have been generic
(cont.)
  • Chemical facility workers
  • Airway obstruction, chronic bronchitis, emphysema
    (Konieczny and Kossman, 1993)
  • Polish organochlorine/carbamate/triazine workers
  • Impaired PFTs, Impaired neutrophil function
    (Sliwinski et al., 1991)
  • Indian mango orchard applicators
  • Pneumonitis (Srivastava et al., 1991) Restrictive
    defect (Garg et al., 1989)

8
Acetylcholinesterase inhibitors
  • Agricultural workers in East Africa
  • Respiratory symptoms (Ohayo-Mitoko et al., 2000)
  • Commercial flower growers
  • Hypersensitivity (carbamates), asthma, rhinitis
    (Ueda et al., 1995)
  • 41 cases exposed to chlorpyrifos
  • Headaches, chest congestion, permanent disability
    (Sherman, 1995)
  • International exposure cases
  • Respiratory allergic symptoms, asthma (Ecobichon,
    1995) (McDuffie and Senthilselvan, 1992)

9
Acetylcholinesterase inhibitors (cont.)
  • Environmental spill exposures
  • Irritant-induced asthma, exacerbation of
    pre-existing asthma (Wugofski, 1994)
  • Combined OP exposures
  • Intermediate syndrome with respiratory paresis
    (De Bleeker et al., 1992)
  • Trialkylphosphorothioates
  • Bronchiolar cell, Clara cell, and Type I
    pneumoocyte damage (Dinsdale, 1992)

10
Paraquat
  • Nicaraguan applicators
  • Chronic nose bleeds, asthma, chronic bronchitis,
    chronic breathlessness (Castro-Gutierrez, 1997)
  • Costa Rican ag workers
  • Pulmonary edema and functional respiratory
    disorders (Hogstedt, 1997)

11
Respiratory cancer
  • Arsenicals
  • Hexamethylphosphoramide (rodents)

12
Few or no published studies
  • Organochlorines
  • Phenoxyacetate herbicides
  • Pyrethroids (mounting body of evidence for
    respiratory allergies)

13
Adverse respiratory function outcomes
  • Acute or persistent episodic airway obstruction
    in the chest (asthma)
  • Chronic obstructive pulmonary disease (COPD)
  • Chronic upper respiratory hyperresponsiveness
    (rhinitis, sinusitis, headaches)
  • Interstitial pulmonary fibrosis
  • Allergy (allergic rhinitis, asthma, pneumonitis)
  • Cancer

14
Pesticide-related respiratory morbidity
  • Largest number of pesticide-related respiratory
    health problems are short-term irritant or
    allergically mediated symptoms without permanent
    sequellae
  • Remaining chronic respiratory disease is mediated
    by direct acute toxicity with repair-related
    long-term dysfunction.

15
Case
  • 36 y.o. male supervisor in a pesticide
    compounding facility
  • Childhood asthma until age 10. Completely
    asymptomatic, off medication, thereafter
  • 3/26/96 Fire in the compounding unit, 30 minute
    exposure to thick, acrid smoke

16
Case
  • Immediate symptoms watery eyes, burning
    sensation of nose and throat, chest tightness,
    dyspnea, wheezing, nausea, vomiting
  • Hospitalized for 24 hours
  • Persistent wheezy cough, nasal and sinus
    congestion, GERD symptoms. Cough worsened by
    exposure to ETS, cooking fumes, cologne.

17
Case Irritant-induced Asthma
  • Physical examination (4/96) swollen nasal
    mucosa, white drainage, decreased nasal airflow.
    Clear lungs.
  • Spirometry FVC-89 FEV1-96
  • Methacholine challenge (5/96) 40 decrease in
    FEV1 at 0.5 mg/ml
  • Bronchoscopy (5/96) airway erythema
  • Sinus x-rays moderate maxillary sinus mucosal
    thickening

18
Irritant-induced Occupational Asthma
  • Synonyms non-immunological asthma, asthma
    without latency
  • Onset 2 types
  • Sudden onset (RADS)
  • Not-so-sudden onset
  • Causal agents a long list of respiratory
    irritants, including gases, fumes and chemicals
    (pesticides)

19
Asthma in the Workplace A broader
classification
() Influenced by setting clinical,
surveillance, compensation systems.
20
Pathogenesis of Asthma
Source Holgate, S.T. and NAEPP Expert Panel
II, 1997
21
Cellular Mechanisms of Inflammation in Asthma
Source NAEPP Expert Panel II, 1997
22
Pulmonary function tests
23
Non-specific bronchial challenge
FEV1 ( of baseline)
albuterol
24
Peak Flow Variability in Asthma
Exposed
Not Exposed
Exposed
Serial Peak Flow Values
25
Asthma Epidemiology U.S.
  • 14-15 million persons (5) affected (5 million in
    the under 18 age group)
  • 100 million days of restricted activity/yr
  • 6.2 billion in annual costs
  • From 1979 to 1992
  • 66 increase in prevalence
  • 17 increase in hospitalization
  • 58 increase in age-adjusted asthma deaths

26
How much of asthma is attributable to
occupational exposures?
  • United States
  • Among Social Security disability applicants
    15.4 (Blanc, 1987)
  • Among HMO members 21 (Milton et al, 1998)
  • Japan 15 (Kobayashi, 1974)
  • Spain 6.7 (Kogevinas et al, 1996)
  • Finland 4.8 (Reijula et al, 1996)
  • Meta-analysis 9 15 among high quality
    studies(Blanc and Toren, 1999)

27
Asthma the bottom line
  • We are dealing with a disease of public health
    importance, with clearly worsening trends in
    prevalence and severity.

28
How much of the worldwide increase in asthma is
due to environmental or occupational pesticide
exposure?
Write a Comment
User Comments (0)
About PowerShow.com